Robotic resection for benign primary retroperitoneal tumors via the transperitoneal approach

Surgical resection is the primary treatment for benign primary retroperitoneal tumors. However, only a few studies have reported robotic resection for retroperitoneal tumors due to the low morbidity rate, and only a small fraction of retroperitoneal tumors are eligible for minimally invasive operations. A retrospective study enrolling 16 patients with benign primary retroperitoneal tumors between November 2016 and April 2020 was conducted to evaluate the efficacy of robotic resection for benign primary retroperitoneal tumors via the transperitoneal approach. Surgical skills were described in detail and operative experiences were summarized. The operations were uneventfully performed without conversion in all the patients. The median operation time was 135 (120–180) min, and the median estimated blood loss was 25 (20–60) mL. The median duration of diet restoration was 2 (1–2) days and the median length of postoperative hospital stay was 6 (4–7) days. No serious intraoperative or postoperative complications occurred during the perioperative period. Robotic resection via the transperitoneal approach is a feasible and safe procedure for highly selected patients with benign primary retroperitoneal tumors, with few postoperative complications and a rapid recovery.